Tag: biotechnology
-
Engineered Algae Doubles Bio-Oil Content
An industry biotechnology team created a genetically-engineered variety of algae that doubles its oil content without limiting its ability to grow.
-
Coalition to Make 10,000 Open-Access Synthetic Genes
A company with a process for creating synthetic DNA and a foundation promoting open access to biotechnology agreed to produce 10,000 synthetic genes made available at no cost to researchers.
-
$300M Fund to Back European Life Science Companies
A new investment fund plans to invest $300 million in European life science and biotechnology companies in the later stages of their product development.
-
First Agricultural Crispr Products Expected by 2020
While the genome editing technique known as Crispr is generating discussion in the health field, its first commercial applications are likely to be in agriculture.
-
Supreme Court Cuts Biosimilar Waiting Time
The U.S. Supreme Court ruled yesterday that makers of biologic drugs similar to branded originals need not wait an additional 6 months to begin marketing their products.
-
Engineered Immune Cells to be Explored for Solid Tumors
A cancer research center and biotechnology company will examine genetically engineered immune system cells as possible treatments for solid tumor cancers.
-
Univ. Spin-Off Discovering New Antibiotics
A new enterprise founded by three microbiologists at Harvard Medical School is licensing the founders’ research to find treatments for antibiotic-resistant bacteria.
-
Bacteria Engineered to Act as Long-Term Gut Sensors
A bioengineering team developed a synthetic form of bacteria that live in the gut, and detect inflammation in lab mice for 6 months.
-
Trial to Test Spherical Nanotech Brain Cancer Drug
An early-stage clinical trial will soon begin testing spherically-shaped nanoscale particles to treat glioblastoma, an aggressive form of brain cancer.
-
Personalized Drug Delivery System Demonstrated
Biomedical engineers developed and demonstrated in lab animals a closed-loop system that monitors and controls delivery of drugs to meet an individual’s personalized needs.